Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT00760669
Eligibility Criteria:
Inclusion Criteria:
* Participants with ankylosing spondylitis who did not show adequate response to general treatments and with increased serological indices related to severe axial symptoms and inflammation
* Participants with rheumatoid arthritis who show insufficient response to disease modifying antirheumatic drug (DMARD) including methotrexate
* Participants with serious, active and progressive disease not previously treated with methotrexate or other DMARD
* Participant with moderate to serious plaque psoriasis who are unresponsive, contra indicant or intolerable to the systemic therapy including cyclosporine, methotrexate or Psoralen Ultra-Violet A (PUVA)
* Participant with active, progressive, psoriatic arthritis who have shown insufficient response to DMARD treatment
Exclusion Criteria:
None
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00760669
Study Brief:
Protocol Section:
NCT00760669